Lucas Bio publishes breakthrough T cell therapy for severe COVID-19 recovery
Lucas Bio publishes breakthrough T cell therapy for severe COVID-19 recovery Lucas Bio announces innovative immune cell therapy for COVID-19 patients needing better treatment...
USC researchers pioneer lifesaving cancer breakthroughs
Several years ago, Heinz-Josef Lenz, a professor of medicine and cancer biology at the Keck School of Medicine...
Researchers Pioneer Lifesaving Cancer Breakthroughs
Several years ago, Heinz-Josef Lenz, a professor of medicine and cancer biology at the Keck School...
New U.S. breakthrough in cancer treatment: Terbium-161
At a research facility in Missouri, scientists are developing a new way to fight cancer that could change how some of the toughest tumors...
Obliteride returns Aug. 9 with more than 5,000 participants powering cancer...
Seattle — July 31, 2025 — Fred Hutch Cancer Center’s summer fundraising event, Obliteride, rolls though Seattle on August 9,...
Can New Drugs Better Control Breakthrough Hemolysis?
TOPLINE:Breakthrough hemolysis (BTH) occured in 10%-15% of patients with paroxysmal nocturnal hemoglobinuria (PNH) over 6 months with eculizumab, crovalimab, and pegcetacoplan, while frequency dropped...
Pharmaceutical Company Discovers Breakthrough Heart Treatment in Canada
View Important Disclosures for this Article
Close
Important Disclosures:
Steve Sobek wrote this article for Streetwise Reports LLC and provides services to Streetwise...
